Global Strategic Alliance & MSA with Image Analysis Group

Key points

• Strategic Alliance with Image Analysis Group (IAG)
• Resonance's MRI analysis endpoints to be integrated into IAG's global imaging business
• Potential access to IAG's global imaging infrastructure and reader network

Full summary

Resonance Health Limited has announced a strategic alliance and master services agreement with Image Analysis Group (IAG), a global imaging clinical research organization. The agreement aims to integrate Resonance's specialized quantitative MRI endpoints into IAG's global clinical trial strategies, providing IAG's customers with access to Resonance's regulatory-cleared Software-as-Medical-Device (SaMD) services. Resonance will also gain access to IAG's imaging infrastructure and reader network, enabling multi-modality clinical trial studies. The alliance targets high-growth indications and is non-exclusive, with an initial term of 24 months and potential renewals.